UBS Says Biomet (BMET) Will Likely Be Bought

Biomet (Nasdaq: BMET) : BMET is a designer, manufacturer and marketer of joint replacement products. BMET hired Morgan Stanley-MS on 4/6/06 to help the company explore strategic alternatives. SNN said on 11/2/06 it held "very preliminary" talks with BMET. UBSW said today 'we think BMET is likely to be bought, but by whom?" BMET over all option implied volatility of 28 is below its 6-month average of 30 according to Track Data, indicating decreasing price risks. Paul Foster